IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.523
EU - Europa 5.333
AS - Asia 3.209
SA - Sud America 566
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 113
OC - Oceania 2
Totale 15.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.286
RU - Federazione Russa 1.373
IE - Irlanda 1.085
SG - Singapore 944
CN - Cina 872
DE - Germania 705
SE - Svezia 551
HK - Hong Kong 464
BR - Brasile 434
VN - Vietnam 433
UA - Ucraina 418
IT - Italia 404
FI - Finlandia 261
FR - Francia 219
IN - India 156
GB - Regno Unito 144
CA - Canada 139
BD - Bangladesh 64
AR - Argentina 46
MX - Messico 46
PL - Polonia 37
ID - Indonesia 36
IR - Iran 36
KR - Corea 36
ZA - Sudafrica 33
JP - Giappone 31
BJ - Benin 30
TR - Turchia 29
ES - Italia 26
BE - Belgio 24
EC - Ecuador 20
CO - Colombia 18
IQ - Iraq 18
AT - Austria 15
LT - Lituania 15
NL - Olanda 15
PK - Pakistan 15
CL - Cile 14
CR - Costa Rica 12
EG - Egitto 12
UZ - Uzbekistan 11
VE - Venezuela 11
PY - Paraguay 10
MA - Marocco 9
TN - Tunisia 9
EU - Europa 8
JM - Giamaica 8
PH - Filippine 8
RO - Romania 8
HN - Honduras 7
SA - Arabia Saudita 7
AL - Albania 6
MY - Malesia 6
UY - Uruguay 6
JO - Giordania 5
PE - Perù 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
DK - Danimarca 4
GT - Guatemala 4
HR - Croazia 4
IL - Israele 4
PA - Panama 4
SV - El Salvador 4
BG - Bulgaria 3
ET - Etiopia 3
KE - Kenya 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
QA - Qatar 3
AU - Australia 2
BS - Bahamas 2
CG - Congo 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EE - Estonia 2
HU - Ungheria 2
LB - Libano 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 15.743
Salva come PNG Salva come JPEG
Città #
Dublin 1.076
Jacksonville 752
San Jose 579
Hong Kong 461
Dearborn 412
Ashburn 378
Singapore 374
Council Bluffs 325
Beijing 274
New York 269
Chandler 217
Wilmington 186
Moscow 165
Los Angeles 159
Ho Chi Minh City 149
Ann Arbor 147
Lauterbourg 141
Lawrence 134
Princeton 134
Columbus 121
Piemonte 104
Hanoi 95
Santa Clara 91
San Mateo 90
Andover 84
Munich 83
Buffalo 78
Toronto 65
São Paulo 58
Bremen 50
Phoenix 50
Grafing 49
Orem 49
Dallas 44
Novara 40
Atlanta 35
Seoul 34
Frankfurt am Main 33
Chicago 32
Denver 32
Redondo Beach 32
Cotonou 30
Houston 29
Brooklyn 28
Helsinki 28
Montreal 28
Tokyo 28
Warsaw 25
Chennai 24
Stockholm 23
Guangzhou 22
Haiphong 22
Mexico City 22
Leawood 21
London 21
Nanjing 21
Brussels 20
Hefei 20
Cave Creek 19
Woodbridge 19
Milan 18
Monmouth Junction 18
Tianjin 18
Zanjan 18
Boardman 17
Manchester 17
Rio de Janeiro 17
Da Nang 16
Hangzhou 16
Johannesburg 16
Philadelphia 16
Seattle 16
Kunming 15
Norwalk 15
Poplar 15
Biên Hòa 14
Mumbai 14
Nuremberg 14
San Francisco 14
Augusta 13
Rome 13
Shanghai 13
Boston 12
Turin 12
Kocaeli 11
Curitiba 10
Jinan 10
Naples 10
Tashkent 10
Turku 10
Ankara 9
Ardabil 9
Bexley 9
Fairfield 9
Hải Dương 9
Jakarta 9
Miami 9
Ninh Bình 9
North Bergen 9
San José 9
Totale 8.649
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 180
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 171
A view on multi-action Pt(IV) antitumor prodrugs 165
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 159
195Pt NMR chemical shift: a chemometric approach 158
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 158
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 152
Transition metal carbonyl clusters in biology: A futile or niche research area? 152
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 152
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 151
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 151
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 151
A different way for the oxidation of the Pt(II) complexes 148
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 147
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 147
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 147
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 145
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 145
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 145
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 142
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 139
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 139
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 139
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 139
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 139
Different strategies to exploit Pt(IV) complexes as pro-drugs 138
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 138
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 138
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 138
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 135
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 133
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 133
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 132
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 131
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 130
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 129
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 126
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 126
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 126
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 123
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 122
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 122
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 121
Pt-195 NMR spectroscopy: A chemometric approach 121
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 120
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 120
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 119
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 119
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 118
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 118
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 117
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 116
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 115
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 115
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 114
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 114
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 114
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 114
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 113
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 113
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 112
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 111
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 110
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 110
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 109
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 109
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 108
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 108
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 108
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 108
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 107
Pt(IV) complexes as anticancer prodrugs 106
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 104
Can an Elusive Platinum(III) Oxidation State be Exposed in an Isolated Complex? 104
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 103
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 102
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 101
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 101
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 101
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 99
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 96
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 95
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 95
Effects of Ferrocene and Ferrocenium on MCF-7 Breast Cancer Cells and Interconnection with Regulated Cell Death Pathways 93
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes 93
Targeting and delivery of Pt(II) antiproliferative drugs 92
Experimental determination and modeling of the lipophilicity in platinum complexes 89
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 89
Online OCHEM multi-task model for solubility and lipophilicity prediction of platinum complexes 88
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 88
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) 88
Elusive Intermediates in the Breakdown Reactivity Patterns of Prodrug Platinum(IV) Complexes 88
The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme 87
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 87
Rhein to impart antimetastatic features to Pt(IV) complexes and to target brain 86
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II)-derivatives 86
Ethynylestradiol-Pt(II) complexes for selective drug targeting 85
Nano-vectors for targeting and delivery of Pt-based anti-tumor drugs 85
Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one 85
Becoming Aware of Endangered and Critical Elements: Spent Batteries as Metal Mines 84
Totale 11.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022788 0 0 0 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/20251.397 16 49 88 25 70 94 158 82 312 156 73 274
2025/20266.086 338 276 470 941 553 420 793 1.006 426 395 299 169
2026/20271.425 256 457 325 387 0 0 0 0 0 0 0 0
Totale 15.937